Paper Details

  1. Home
  2. Paper Details

Treating the substance-abusing suicidal patient.

Author: ClarkD B, CorneliusJ R, LynchK, MannJ J, SalloumI M

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

Suicidal behavior is common among substance-abusing patients, but treatment studies are limited due to the exclusion of this population. Fluoxetine has shown promise in reducing depressive symptoms, including suicidal ideation, and alcohol consumption in a study of substance-abusing suicidal patients. However, the effects were not complete, and further research is needed to evaluate the effectiveness of various pharmacotherapies and psychotherapies for this population.
Paper Details　
Original Abstract of the Article :
Studies concerning the treatment of substance-abusing suicidal patients are scarce despite the frequent presence of suicidal behavior among this population. Indeed, suicidality (ideation or behavior) is generally an exclusion criterion for participation in treatment studies of subjects with alcohol ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1749-6632.2001.tb05799.x

データ提供：米国国立医学図書館（NLM）

Navigating the Intersection of Substance Abuse and Suicidal Behavior: A Complex Landscape for Treatment

This study delves into the complex and challenging realm of mental health, exploring the treatment of substance-abusing suicidal patients. The researchers highlight the scarcity of research in this area and the unique challenges associated with treating this vulnerable population. The study provides a comprehensive overview of the limited evidence base, highlighting the need for further research to develop effective and compassionate approaches to care.

Fluoxetine: A Beacon of Hope in the Darkness

This study explores the potential efficacy of fluoxetine, a commonly used antidepressant, in treating both suicidal ideation and substance abuse in patients with comorbid major depressive disorder and alcohol dependence. The researchers found encouraging evidence that fluoxetine may be effective in reducing both depressive symptoms and alcohol consumption.

Bridging the Gap: The Need for Comprehensive Treatment Approaches

This study emphasizes the importance of a multidisciplinary approach to treating substance-abusing suicidal patients. The researchers highlight the need for integrated care models that address both mental health and substance abuse issues. By combining pharmacotherapy, psychotherapy, and supportive services, we can provide more comprehensive and effective treatment, offering hope and support to patients struggling with these complex challenges.

Dr. Camel's Conclusion

This study, like a lone traveler seeking solace in the desert, underscores the complexity and challenge of treating substance-abusing suicidal patients. While the research base remains limited, promising findings suggest that fluoxetine may offer a glimmer of hope. Further research is needed to develop more comprehensive and effective treatment approaches, ensuring that these vulnerable individuals receive the care they need.

Date :
  1. Date Completed 2001-08-23
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

11411192

DOI: Digital Object Identifier

10.1111/j.1749-6632.2001.tb05799.x

Related Literature

Article Analysis
・Effective treatment of suicide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.